CDC. Mpox 2022 Outbreak cases and data 2023 [Available from: https://www.cdc.gov/poxvirus/mpox/response/2022/index.html.
Mitjà O, Ogoina D, Titanji BK, Galvan C, Muyembe JJ, Marks M, et al. Monkeypox Lancet. 2023;401(10370):60–74.
•• Mitjà O, Alemany A, Marks M, Lezama Mora JI, Rodríguez-Aldama JC, Torres Silva MS, et al. Mpox in people with advanced HIV infection: a global case series. Lancet. 2023;401(10380):939–49. ()
Govind A, Lazarte SM, Kitchell E, Chow JY, Estelle CD, Fixsen E, et al. Severe mpox infections in people with uncontrolled human immunodeficiency virus. Clin Infect Dis. 2023;76(10):1843–6.
O’Shea J, Daskalakis D, Brooks JT. The emergence of mpox as an HIV-related opportunistic infection. Lancet. 2023;401(10384):1264.
Article PubMed PubMed Central Google Scholar
Lansiaux E, Jain N, Laivacuma S, Reinis A. The virology of human monkeypox virus (hMPXV): a brief overview. Virus Res. 2022;322:198932.
Article CAS PubMed Google Scholar
Li H, Huang QZ, Zhang H, Liu ZX, Chen XH, Ye LL, et al. The land-scape of immune response to monkeypox virus. EBioMedicine. 2023;87:104424.
Article CAS PubMed Google Scholar
Lum FM, Torres-Ruesta A, Tay MZ, Lin RTP, Lye DC, Rénia L, et al. Monkeypox: disease epidemiology, host immunity and clinical interventions. Nat Rev Immunol. 2022;22(10):597–613.
Article CAS PubMed PubMed Central Google Scholar
Song H, Josleyn N, Janosko K, Skinner J, Reeves RK, Cohen M, et al. Monkeypox virus infection of rhesus macaques induces massive expansion of natural killer cells but suppresses natural killer cell functions. PLoS ONE. 2013;8(10):e77804.
Article CAS PubMed PubMed Central Google Scholar
Tarín-Vicente EJ, Alemany A, Agud-Dios M, Ubals M, Suñer C, Antón A, et al. Clinical presentation and virological assessment of confirmed human monkeypox virus cases in Spain: a prospective observational cohort study. The Lancet. 2022;400(10353):661–9.
Karem KL, Reynolds M, Hughes C, Braden Z, Nigam P, Crotty S, et al. Monkeypox-induced immunity and failure of childhood smallpox vaccination to provide complete protection. Clin Vaccine Immunol. 2007;14(10):1318–27.
Article CAS PubMed PubMed Central Google Scholar
Nagata N, Saijo M, Kataoka M, Ami Y, Suzaki Y, Sato Y, et al. Pathogenesis of fulminant monkeypox with bacterial sepsis after experimental infection with West African monkeypox virus in a cynomolgus monkey. Int J Clin Exp Pathol. 2014;7(7):4359–70.
PubMed PubMed Central Google Scholar
•• Earl PL, Americo JL, Moss B. Natural killer cells expanded in vivo or ex vivo with IL-15 overcomes the inherent susceptibility of CAST mice to lethal infection with orthopoxviruses. PLoS Pathog. 2020;16(4):1008505. ()
Mikulak J, Oriolo F, Zaghi E, Di Vito C, Mavilio D. Natural killer cells in HIV-1 infection and therapy. AIDS. 2017;31(17):2317–30.
Article CAS PubMed Google Scholar
Strassburg MA. The global eradication of smallpox. Am J Infect Control. 1982;10(2):53–9.
Article CAS PubMed Google Scholar
McIntosh K, Cherry JD, Benenson AS, Connor JD, Alling DW, Rolfe UT, et al. Clinical and serologic study of four smallpox vaccines comparing variations of dose and route of administration. Standard percutaneous revaccination of children who receive primary percutaneous vaccination. J Infect Dis. 1977;135(1):155–66.
Article CAS PubMed Google Scholar
Kempe CH, Bowles C, Meiklejohn G, Berge TO, St Vincent L, Babu BV, et al. The use of vaccinia hyperimmune gamma-globulin in the prophylaxis of smallpox. Bull World Health Organ. 1961;25(1):41–8.
CAS PubMed PubMed Central Google Scholar
Moir S, Fauci AS. B-cell responses to HIV infection. Immunol Rev. 2017;275(1):33–48.
Article CAS PubMed PubMed Central Google Scholar
Swain SL, McKinstry KK, Strutt TM. Expanding roles for CD4+ T cells in immunity to viruses. Nat Rev Immunol. 2012;12(2):136–48.
Article CAS PubMed PubMed Central Google Scholar
•• Edghill-Smith Y, Golding H, Manischewitz J, King LR, Scott D, Bray M, et al. Smallpox vaccine-induced antibodies are necessary and sufficient for protection against monkeypox virus. Nat Med. 2005;11(7):740–7. ()
Article CAS PubMed Google Scholar
•• Thornhill JP, Barkati S, Walmsley S, Rockstroh J, Antinori A, Harrison LB, et al. Monkeypox virus infection in humans across 16 countries — April–June 2022. New England J Med. 2022;387(8):679–91. ()
Fajgenbaum DC, June CH. Cytokine Storm. N Engl J Med. 2020;383(23):2255–73.
Article CAS PubMed PubMed Central Google Scholar
Johnston SC, Johnson JC, Stonier SW, Lin KL, Kisalu NK, Hensley LE, et al. Cytokine modulation correlates with severity of monkeypox disease in humans. J Clin Virol. 2015;63:42–5.
Article CAS PubMed Google Scholar
Johnson RF, Dyall J, Ragland DR, Huzella L, Byrum R, Jett C, et al. Comparative analysis of monkeypox virus infection of cynomolgus macaques by the intravenous or intrabronchial inoculation route. J Virol. 2011;85(5):2112–25.
Article CAS PubMed Google Scholar
O’Shea J, Filardo TD, Morris SB, Weiser J, Petersen B, Brooks JT. Interim guidance for prevention and treatment of monkeypox in persons with HIV infection - United States, August 2022. MMWR Morb Mortal Wkly Rep. 2022;71(32):1023–8.
Article PubMed PubMed Central Google Scholar
Hoffmann C, Jessen H, Wyen C, Grunwald S, Noe S, Teichmann J, et al. Clinical characteristics of monkeypox virus infections among men with and without HIV: a large outbreak cohort in Germany. HIV Med. 2023;24(4):389–97.
Miller MJ, Cash-Goldwasser S, Marx GE, Schrodt CA, Kimball A, Padgett K, et al. Severe monkeypox in hospitalized patients - United States, August 10-October 10, 2022. MMWR Morb Mortal Wkly Rep. 2022;71(44):1412–7.
Article PubMed PubMed Central Google Scholar
Rao AK, Schrodt CA, Minhaj FS, Waltenburg MA, Cash-Goldwasser S, Yu Y, et al. Interim clinical treatment considerations for severe manifestations of mpox - United States, February 2023. MMWR Morb Mortal Wkly Rep. 2023;72(9):232–43.
Article PubMed PubMed Central Google Scholar
Grosenbach DW, Honeychurch K, Rose EA, Chinsangaram J, Frimm A, Maiti B, et al. Oral tecovirimat for the treatment of smallpox. N Engl J Med. 2018;379(1):44–53.
Article CAS PubMed PubMed Central Google Scholar
CDC. Demographics of patients receiving TPOXX for treatment of mpox 2023 [Available from: https://www.cdc.gov/poxvirus/mpox/response/2022/demographics-TPOXX.html. Accessed 1 Sept 2023
O’Laughlin K, Tobolowsky FA, Elmor R, Overton R, O’Connor SM, Damon IK, et al. Clinical use of tecovirimat (Tpoxx) for treatment of monkeypox under an investigational new drug protocol - United States, May-August 2022. MMWR Morb Mortal Wkly Rep. 2022;71(37):1190–5.
Article CAS PubMed PubMed Central Google Scholar
McLean J, Stoeckle K, Huang S, Berardi J, Gray B, Glesby MJ, et al. Tecovirimat treatment of people with HIV during the 2022 mpox outbreak : a retrospective cohort study. Ann Intern Med. 2023;176(5):642–8.
Article PubMed PubMed Central Google Scholar
Riser AP, Hanley A, Cima M, Lewis L, Saadeh K, Alarcón J, et al. Epidemiologic and clinical features of mpox-associated deaths - United States, May 10, 2022-March 7, 2023. MMWR Morb Mortal Wkly Rep. 2023;72(15):404–10.
Article PubMed PubMed Central Google Scholar
Andrei G, Snoeck R. Cidofovir activity against poxvirus infections. Viruses. 2010;2(12):2803–30.
Article CAS PubMed PubMed Central Google Scholar
Stafford A, Rimmer S, Gilchrist M, Sun K, Davies EP, Waddington CS, et al. Use of cidofovir in a patient with severe mpox and uncontrolled HIV infection. Lancet Infect Dis. 2023;23(6):e218–26.
Article CAS PubMed PubMed Central Google Scholar
Raccagni AR, Candela C, Bruzzesi E, Mileto D, Canetti D, Rizzo A, et al. Real-life use of cidofovir for the treatment of severe monkeypox cases. J Med Virol. 2023;95(1):e28218.
Article CAS PubMed Google Scholar
Adler H, Gould S, Hine P, Snell LB, Wong W, Houlihan CF, et al. Clinical features and management of human monkeypox: a retrospective observational study in the UK. Lancet Infect Dis. 2022;22(8):1153–62.
Comments (0)